Eventide Asset Management - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 265 filers reported holding IMMUNOGEN INC in Q2 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.4%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q2 2023$24,531,000
+415.4%
1,300,000
+30.0%
0.42%
+453.3%
Q1 2022$4,760,000
-35.8%
1,000,0000.0%0.08%
-21.1%
Q4 2021$7,420,0001,000,0000.10%
Other shareholders
IMMUNOGEN INC shareholders Q2 2023
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 6,029,592$113,778,40116.04%
Redmile Group, LLC 17,730,417$334,572,96912.84%
CM Management, LLC 500,000$9,4359.20%
SILVERARC CAPITAL MANAGEMENT, LLC 1,420,000$26,795,4008.29%
Altium Capital Management LP 485,000$9,151,9506.93%
Connective Portfolio Management, LLC 78,000$1,469,0003.64%
TANG CAPITAL MANAGEMENT LLC 1,300,000$24,531,0003.61%
Artia Global Partners LP 543,358$10,253,1653.53%
Velan Capital Investment Management LP 189,500$3,575,8653.32%
BRIDGER MANAGEMENT, LLC 467,220$8,816,4412.94%
View complete list of IMMUNOGEN INC shareholders